Glucophage XR is the brand-name, extended-release form of metformin, the most widely prescribed medication for type 2 diabetes. Each tablet contains either 500 mg or 750 mg of metformin hydrochloride, designed to release the drug slowly over several hours so you only need to take it once a day with your evening meal.
How Glucophage XR Lowers Blood Sugar
Metformin works on three fronts. It reduces the amount of sugar your liver produces, slows sugar absorption from food in your intestines, and helps your cells respond better to insulin so they pull more glucose out of the bloodstream. Unlike some diabetes medications, metformin does not force your pancreas to produce extra insulin, which is one reason it carries a low risk of causing blood sugar to drop too low on its own.
What makes Glucophage XR different from regular metformin tablets is its delivery system. The tablet uses a dual-layer polymer design: the drug is embedded in one polymer and then wrapped in a second. When you swallow it and fluid enters the tablet, both polymers swell into a gel. The metformin then slowly diffuses out through that gel over hours, regardless of your stomach’s acidity. This means your body gets a steady, gradual supply of the drug rather than a single spike.
Extended Release vs. Immediate Release
Regular metformin (Glucophage) is typically taken two or three times a day. Glucophage XR delivers the same total amount of drug to your body but in a single daily dose. The peak blood level is about 80% of what you’d see with an equivalent immediate-release dose, but overall drug exposure across the day is comparable. That peak arrives around seven hours after you take it, compared to roughly two to three hours with regular metformin.
The lower, more gradual peak is one reason many people find the extended-release version easier on the stomach. Gastrointestinal side effects are the most common reason people stop taking metformin, so doctors often switch patients to the XR formulation when the regular version causes persistent nausea or diarrhea.
Common Side Effects
In clinical trials involving 781 patients on Glucophage XR and 195 on placebo, two side effects occurred in more than 5% of patients taking the drug:
- Diarrhea: 9.6% of Glucophage XR patients vs. 2.6% on placebo
- Nausea or vomiting: 6.5% vs. 1.5% on placebo
These effects are most common when you first start the medication or increase your dose, and they usually improve within a few weeks. Only 0.6% of patients in those trials stopped taking the drug because of diarrhea. Taking the tablet with food helps, and it’s not optional: when Glucophage XR is taken with a meal, absorption increases by about 50%.
Effects on Body Weight
Metformin is one of the few diabetes medications associated with modest weight loss rather than weight gain. In the large Diabetes Prevention Program study, participants on metformin lost an average of 2.1 kg (about 4.6 pounds) over roughly three years, compared to almost no change in the placebo group. About 30% of people on metformin lost more than 5% of their body weight in the first year, and those individuals maintained an average 6.2% loss after 15 years of follow-up.
The weight loss is real but modest for most people. A meta-analysis of 21 trials found metformin reduced BMI by about 1.3 points on average in people with obesity. There’s no meaningful difference between immediate-release and extended-release formulations when it comes to weight effects.
How It’s Taken
The standard starting dose is 500 mg once daily, taken with your evening meal. Your dose is gradually increased in 500 mg steps each week until your blood sugar is well controlled, up to a maximum of 2,000 mg per day. All of it is taken at once with dinner. You should swallow the tablet whole rather than crushing or splitting it, since breaking the tablet disrupts the slow-release design.
You may occasionally notice what looks like a whole tablet in your stool. This is the empty shell of the polymer matrix after the drug has been absorbed. It’s normal and doesn’t mean the medication isn’t working.
Vitamin B12 and Long-Term Use
Long-term metformin use can reduce your body’s absorption of vitamin B12. Over years, this can lead to deficiency, which may cause anemia or nerve-related symptoms like tingling or numbness in the hands and feet. If you’ve been on metformin for several years, periodic B12 monitoring is recommended, especially if you have other risk factors for deficiency such as a diet low in animal products or a history of digestive conditions.
Lactic Acidosis Warning
Metformin carries an FDA boxed warning for a rare but serious condition called lactic acidosis, where lactic acid builds up in the blood faster than the body can clear it. In practice, this is uncommon in people with healthy kidneys and liver function. Early symptoms are vague: unusual muscle pain, feeling cold, trouble breathing, feeling unusually sleepy, or unexplained stomach pain.
The risk increases with kidney problems, liver disease, heavy alcohol use, severe dehydration, being 65 or older, or having a procedure that uses contrast dye for imaging. Because the kidneys are the main route for clearing metformin from the body, kidney function is the key safety check. Glucophage XR is not started in people whose kidney filtration rate (eGFR) falls below 30, and starting it is generally not recommended when eGFR is between 30 and 45. If kidney function declines while you’re already taking it, your doctor will reassess whether continuing is appropriate.